The role of CD4+ T and B lymphocytes is controversial in many cancers including STS; CD4+ cells in the absence of the CD8+ cytotoxic T cells are critical and sufficient for NKT cell-dependent rejection of experimental tumours[27]. This evidence concerns the gene CD4 and cancer.